TECHNICAL-SCIENTIFIC CAPABILITIES
microscopIA brings together epidemiology, quantitative methods, data science, biostatistics, AI, engineering, health economics, geospatial analysis, evidence synthesis, clinical research, policy, implementation and scientific publication where relevant.
A capability is not claimed as a guarantee. Scope, evidence, people and responsibilities are confirmed project by project.
TWELVE CAPABILITY AREAS
Each capability links to public proof where available and to the correct partnership workflow.
Have a clinical question or a dataset? We help choose the right study design, define the population and outcomes, and address bias before drawing conclusions.
Make sense of clinical or operational data: define the analysis, compare groups, account for important differences and quantify uncertainty.
Develop or evaluate AI through data, model, validation, clinical, economic and implementation stages as appropriate.
Translate healthcare needs into specifications, prototypes, evaluation and responsible evidence.
Compare the costs and health outcomes of treatments or services. If your team has outcome and resource-use data, we can assess which option offers better value, what it would cost to implement and how uncertain the decision remains.
Measure geographic access, travel time, service coverage and health-system gaps.
Answer focused questions through transparent review, meta-analysis and consensus methods.
Turn a clinical question into a protocol with clear eligibility, outcomes and analysis. We define the scientific support you need; trial sponsorship, clinical delivery and regulatory responsibilities require separate agreements.
Combine epidemiology, synthesis, economics, geospatial modeling and implementation evaluation into decision-ready evidence.
Move from intervention and metrics to deployment, evaluation, value assessment and scale decisions.
Develop an accountable publication pathway as a scientific team—not a writing vendor, ghostwriter or authorship marketplace.
Extend research, innovation and evidence capacity through a defined external partnership.
RESPONSIBLE INNOVATION LIFECYCLES
